Turning Scientific Possibilities Into Medical Progress
Drug discovery has always required patience, careful research, and a willingness to explore possibilities that may not lead to immediate answers. Today, artificial intelligence is adding a new dimension to this work. By helping researchers examine large datasets, identify potential drug targets, and study promising compounds, AI is changing how early-stage research is approached.
Yet discovering a potential drug is far from a simple process. Scientific evidence must be examined, results must be validated, and promising findings must withstand years of research and testing. AI can help researchers make sense of complex information, but it is human expertise that gives those findings direction and determines how they can be applied.
At Life Sciences Business Outlook, we recognize the growing role of AI in shaping pharmaceutical research and development. Its value lies not simply in speed, but in helping scientists ask better questions, explore less obvious possibilities, and make more informed research decisions. As these tools become more capable, the need for responsible development, reliable data, and scientific oversight remains equally important.
In this edition, we explore the changing landscape of AI-driven drug discovery and the platforms helping researchers approach complex scientific challenges in new ways. We are also pleased to present the AI Drug Discovery Platform of the Year 2026 Award, recognizing a platform making a meaningful contribution to the advancement of AI-powered drug research.
We hope this edition gives readers a closer look at the people, ideas, and technologies shaping the next chapter of drug discovery.
Josh Eckman
CEO
Salt Lake City, UT
carterra-bio.com
Carterra develops high-throughput surface plasmon resonance (HT-SPRâ„¢) technologies that help accelerate drug discovery by generating rich, quantitative data on molecular interactions. Its platforms enable researchers to evaluate large numbers of molecules while measuring binding affinity and kinetics. Carterra supports AI-driven discovery, lab-in-the-loop workflows, and emerging approaches spannin...